The Saskatchewan government says it will now cover the cost of two drugs used to treat alcohol addiction.

The Saskatchewan Prescription Drug Plan now provides coverage for Revia (naltrexone) and Campral (acamprosate).

“Our government is committed to providing services to help people struggling with addictions,” Health Minister Jim Reiter said in a news release Wednesday.

“These products are an important addition to the continuum of alcohol treatment services offered throughout Saskatchewan.”

Both drugs are used as part of an alcohol counselling program. Naltrexone is used to take away the cravings for alcohol, while acamprosate is used to maintain abstinence from alcohol in clients who have already stopped drinking.

The province recently expanded access to brief detox programming in Prince Albert, Saskatoon and Regina.

In 2015-16, there were more than 30,000 admissions to addictions services in Saskatchewan.